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ABSTRACT 
Background: Malignant mammary tumors in humans and bitches cause hematological disorders such as anemia, eryth-
rocytosis, thrombocytosis, hyperproteinemia, and leucopenia. Novel studies have been conducted on the predictive and 
prognostic values of platelet (PLT) indices in human breast cancer (HBC). However, there is little information about the 
alterations in hematological parameters in canine mammary tumors (CMTs). The aims of this study were to evaluate the 
platelet indices and complete blood count (CBC) parameters in bitches with and without mammary tumor and to assess 
the above mentioned parameters with regard to histological tumor types and grades.
Materials, Methods & Results: A total of 71 bitches were enrolled in this study. The bitches in the study group were di-
vided into 2 groups which consisted of malignant epithelial mammary tumors (group EMT; n = 43) and malignant mixed 
mammary tumors (group MMT; n = 12). Control group (group C) consisted of clinically and gynaecologically healthy 16 
bitches. Blood samples were obtained to perform the CBC and PLT indices analysis. Histopathological examinations were 
carried out under a light microscope. Histological tumor types and malignancy grades were classified. The bitches with 
mammary tumor showed significantly increased PLT values and decreased hematocrit (HCT), hemoglobin (HGB) and mean 
corpuscular hemoglobin (MCH) values versus the healthy ones, regardless of the tumor type. However, in comparisons 
with the group C, mean platelet volume (MPV) and mean corpuscular hemoglobin concentration (MCHC) values were 
different only in the group MMT, while plateletcrit (PCT) and mean corpuscular volume (MCV) values were different only 
in the group EMT. Also white blood cell (WBC), PLT and PCT values were higher than the referenced laboratory ranges 
in grade 3 tumors. In the presented study, MPV was considerably correlated with PLT, platelet distribution width (PDW) 
and PCT. Also, PCT and PLT had high sensitivity and specificity to distinct EMT and MMT from the healthy bitches.
Discussion: Microcytic and hypochromic anemia occurs due to the decrease in the amount of HGB. Levels of MCV, MCH, 
and MCHC in the HBC group were reported to be significantly lower than in humans without breast cancer. Although 
anemia did not occur in EMT and MMT groups, obtained significances in the HCT, HGB, MCV, MCH, and MCHC levels 
between the bitches with and without mammary tumor were in line with the previous reports. In this study, WBC levels 
in grade 3 tumors were significantly higher than grade1 tumors (P < 0.05). Whereas levels of WBC in grade 1 and grade 
2 tumors were in referenced laboratory ranges, it was higher in grade 3. Increased level of WBC in grade 3 was supposed 
to be due to the rise in malignancy as previously reported. Thrombocytosis was detected in 48.83% and 41.66% of the 
bitches in EMT and MMT groups, respectively. The higher percentage of CMTs with thrombocytosis in this study might be 
due to the difference in referenced upper limit of PLT in previous studies. The elapsed time between tumor formation and 
clinical presentation could be another influencing factor. Although PLT and PCT values were not significant according to 
the histological grading in this study, both parameters were found to be higher in grade 3 than the normal reference values. 
Further studies conducted with higher populations may lead the differences in these parameters to significance. With the 
support of further studies, alterations in the above mentioned parameters in bitches may contribute in the diagnosis pro-
cess, management of treatment and may constitute an easy way to have an idea about the prognosis of mammary tumors.
Keywords: bitches, grade, hematology, mammary tumor, platelet indices.
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INTRODUCTION 
Mammary tumors are the most common 
neoplasms in intact bitches [33]. Although mammary 
tumors mostly derive from epithelial origin, there are 
also tumors with mixed histology that consist of epi-
thelial and myoepithelial tissue. Epithelial tumors are 
often classified according to histopathologic borders 
and differentiation [14]. There are few mammary 
tumors that are entirely of mesenchymal origin [30]. 
Malignant mixed tumors which represent 20% to 
32% of all the malignant mammary tumors consist of 
epithelial components and connective tissue like cells 
[11]. Malignant mixed tumors and carcinosarcomas are 
aggressive tumors, with poor prognosis [10]. Similar 
clinical, pathological and molecular features exist 
between CMTs and human breast cancer (HBC) [31]. 
Due to these similarities, CMTs provide an excellent 
model for HBC [1]. Malignant mammary tumors in 
humans [24] and in bitches [21] cause hematological 
disorders such as anemia, erythrocytosis, thrombo-
cytosis, hyperproteinemia, and leucopenia. With the 
introduction of more up-to-date and better working 
complete blood count (CBC) devices, the roles of 
platelet (PLT) indices have been understood. Novel 
studies exist on predictive and prognostic values of 
PLT indices in HBC [15,22,35]. However, there is 
little information about the alterations in hematologi-
cal parameters in CMTs. The aims of this study were 
to evaluate the PLT indices and CBC parameters in 
bitches with and without mammary tumor and to as-
sess the above mentioned parameters with regard to 
histological tumor types and grades.
MATERIALS AND METHODS
Animals
A total of 71 bitches were enrolled in this study. 
The study group consisted of 55 bitches which had 
a tumor in a single mammary gland. Control group 
(Group C) consisted of clinically and gynaecologically 
healthy 16 bitches which were presented to the clinic 
for ovariohysterectomy. The ages and weights of the 
bitches in group C ranged from 2 to 9 years and from 
5 to 35 kg. The bitches in the study group were divided 
into 2 groups which consist of malignant epithelial 
mammary tumors (group EMT; n = 43) and malignant 
mixed mammary tumors (group MMT; n = 12). The 
ages and weights of the bitches in group EMT ranged 
from 7 to 18 years and from 5 to 50 kg whereas the 
ages and weights of the bitches in group MMT ranged 
from 8 to 16 and from 5 to 55 kg.
Clinical examination and surgery
Three-view thoracic radiography1 and total 
blood count2 were performed in order to evaluate the 
preoperative anesthesia risks in all groups. Blood sam-
ples were obtained via the puncture of the vena cephal-
ica antebrachii by using sterile 18 gauge cannula into 
the ethylendiaminetetra-acetic acid (EDTA) containing 
vacutainer tube3. Red blood cell (RBC), hemoglobin 
(HGB), hematocrit (HCT), white blood cell (WBC), 
mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC), PLT, mean platelet volume 
(MPV), platelet distribution width (PDW), plateletcrit 
(PCT) measurements were incorporated into the study. 
Mastectomy was performed under general anesthesia 
for each bitch in the study group. Initially, the bitches 
were premedicated with atropine sulfate4 (0.04 mg/
kg, sc). The anesthesia was induced by 1% propofol5 
(6 mg/kg, iv) and maintained with 3-3.5% isoflurane6 
and 1-2% oxygen combination. Anesthesia protocol 
was the same for the bitches in group C. 
Histopathological examination
Freshly collected canine mammary samples 
were fixed in 10% neutral buffered formalin, embed-
ded in paraffin, sectioned at 4 μm and stained with 
hematoxylin and eosin8. Histopathological examination 
was carried out under a light microscope7. Histological 
tumor types and malignancy grades were classified as 
reported by Goldschmidt et al. [14].
Statistical analysis
Statistical analyses were performed with 
SPSS 13.0 package program9. Normal distribution 
of data was checked by using the Shapiro-Wilk test. 
Oneway Anova was performed for the comparison of 
the groups with regard to the hematological param-
eters. The Pearson correlation was used to determine 
the relationships among the parameters evaluated. 
Values were given as mean ± standard error of the 
mean (SEM). Receiver-operating characteristics 
(ROC) curve analysis was performed to determine 
sensitivity and specificity of PLT, MPV, PDW and 
PCT in group EMT and group MMT. The significance 
level was accepted as P < 0.05.
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RESULTS
In group C, the mean age and weight of the 
bitches were 5 ± 0.87 years and 15.25 ± 2.61 kg. The 
mean ages and weights of the bitches in group EMT and 
group MMT were 10.86 ± 0.39 years, 15.96 ± 1.82 kg and 
10.83 ± 0.79 years, 24 ± 4.26 kg; respectively. Histologi-
cal tumor types in group EMT were in situ carcinoma (n 
= 2), ductal carcinoma (n = 1), simple carcinoma (n = 30), 
solid carcinoma (n = 2), complex carcinoma (n = 6) and 
intra-ductal papillary carcinoma (n = 2). The numbers 
of affected bitches with regard to histological grading in 
group EMT were grade 1 (n = 12), grade 2 (n = 19) and 
grade 3 (n = 12). However, group MMT had comprised 
of grade 2 (n = 5) and grade 3 (n = 7). Mean values and 
SEM of PLT indices and CBC parameters related to the 
groups and their significance were given in Table 1. The 
levels of PLT were above the referenced laboratory range 
[27] in 21 bitches of group EMT and in 5 bitches of group 
MMT. The comparison of the histological grading in the 
study group (both EMT and MMT) with regard to the PLT 
indices and CBC parameters was presented in Table 2. 
Besides, histological grading in groups EMT and MMT 
were separately compared in terms of the PLT indices and 
CBC parameters. In group EMT, the mean MCHC value 
tended to be higher in grade 1 than grade 3 (P = 0.071) and 
the mean WBC value in grade 3 tended to be higher than 
grade 2 (P = 0.074). In group MMT, histological grades 
were not significantly associated with any parameters (P 
> 0.05). The relationships among the PLT indices and 
CBC parameters were detailed in Table 3. Cut-off points, 
sensitivity and specificity of PLT, PDW and PCT in group 
EMT and group MMT were clarified in Table 4. Due to 
the low sensitivity and specificity percentages of MPV, 
the cut-off value was not specified.
Table 1. The mean values and SEM of platelet indices and complete blood count parameters and their significances related to the groups.
Parameter EMT (n = 43) MMT (n = 12) C (n = 16) P
PLT, K/μL 466.37 ± 29.59a 441 ± 72.63a 290.38 ± 18.21b **
MPV, fL 10.54 ± 0.27ab 10.31 ± 0.42a 11.61 ± 0.25b *
PDW, fL 11.90 ± 0.24a 12.53 ± 0.66a 11.28 ± 0.41a ns
PCT, % 0.46 ± 0.02a 0.43 ± 0.06ab 0.33 ± 0.01b *
RBC, M/μL 6.55 ± 0.15a 6.55 ± 0.30a 7.06 ± 0.21a ns
HCT, % 41.23 ± 1.06a 41.64 ± 2.32a 46.21 ± 1.29b *
HGB, g/dL 14.71 ± 0.34a 14.46 ± 0.89a 16.84 ± 0.47b **
MCV, fL 62.90 ± 0.53a 63.30 ± 1.15ab 65.51 ± 0.70b *
MCH, pg 22.49 ± 0.18a 21.90 ± 0.53a 23.86 ± 0.19b ***
MCHC, g/dL 35.78 ± 0.23a 34.59 ± 0.47b 36.47 ± 0.19a **
WBC, K/μL 14.46 ± 1.49a 15.71 ± 2.78a 11.56 ± 0.84a ns
EMT: Epithelial mammary tumor; MMT: Malignant mammary tumor; C: Control; PLT: Platelet; MPV: Mean platelet volume; PDW: Platelet 
distribution width; PCT: Plateletcrit; RBC: Red blood cell; HGB: Hemoglobin; HCT: Hematocrit; WBC: White blood cell; MCV: Mean 
corpuscular volume; MCH: Mean corpuscular hemoglobin; MCHC: Mean corpuscular hemoglobin concentration; a,b: Values not sharing the 
same superscript in the same line were significant. *: P < 0.05; **: P < 0.01; ***: P < 0.001; ns: P >0.05.
Table 2. The mean values and SEM of platelet indices and complete blood count parameters related to histological grading.
Parameter Grade 1 (n = 12) Grade 2 (n = 24) Grade 3 (n = 19) P
PLT, K/μL 413.92 ± 39.78 451.58 ± 44.23 502.16 ± 52.26 ns
MPV, fL 10.81 ± 0.60 10.71 ± 0.40 10.01 ± 0.23 ns
PDW, fL 11.56 ± 0.59 12.22 ± 0.39 12.12 ± 0.33 ns
PCT, % 0.42 ± 0.02 0.44 ± 0.03 0.49 ± 0.04 ns
RBC, M/μL 6.75 ± 0.25 6.48 ± 0.18 6.52 ± 0.27 ns
HCT, % 42.38 ± 1.75 40.90 ± 1.41 41.17 ± 1.88 ns
HGB, g/dL 15.47 ± 0.56 14.49 ± 0.43 14.35 ± 0.69 ns
MCV, fL 62.75 ± 0.88 63.07 ± 0.83 63.02 ± 0.78 ns
MCH, pg 22.94 ± 0.32 22.41 ± 0.30 21.93 ± 0.30 ns
MCHC, g/dL 36.59 ± 0.41a 35.57 ± 0.33ab 34.79 ± 0.30b **
WBC, K/μL 13.45 ± 2.31a 11.79 ± 0.81ab 19.27 ± 3.15b *
RBC: Red blood cell; HGB: Hemoglobin; HCT: Hematocrit; WBC: White blood cell; MCV: Mean corpuscular volume; MCH: Mean corpuscu-
lar hemoglobin; MCHC: Mean corpuscular hemoglobin concentration; PLT: Platelet; MPV: Mean platelet volume; PDW: Platelet distribution 
width; PCT: Plateletcrit; a,b: Values not sharing the same superscript in the same line were significant. *: P < 0.05; **: P < 0.01; ns: P > 0.05.
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Table 4. Cut-off points, sensitivity, and specificity of PLT, PDW and PCT in group EMT and group MMT.
Group EMT Group MMT
Parameter Cut-off point Sensitivity % Specificity % Cut-off point Sensitivity % Specificity %
PLT, K/μL 420 62 93 370 58 87
PDW, fL 11.3 60 68 11.25 75 68
PCT, % 0.4 60 81 0.4 58 81
EMT: Epithelial mammary tumor; MMT: Malignant mammary tumor; PLT: Platelet; PDW: Platelet distribution width; PCT: Plateletcrit.
DISCUSSION
 In bitches, mammary tumors are the most 
common neoplasms with a median age of occurrence 
between 9 and 11 years [9]. In this study, the mean ages 
of the bitches in groups EMT and MMT were similar 
with the previous report [9]. Anemia is one of the para-
neoplastic syndromes in veterinary oncology [5] and it 
was positively correlated with tumor hypoxia in cancer 
patients [12]. Low HGB levels were correlated with 
higher amounts of tumor hypoxia with poorer progno-
sis [38]. Microcytic and hypochromic anemia occurs 
due to the decrease in the amount of HGB [8]. Levels of 
MCV, MCH, and MCHC in HBC group were reported 
to be significantly lower than in humans without breast 
cancer [28]. Although anemia had not been formed in 
EMT and MMT groups, obtained significances in the 
HCT, HGB, MCV, MCH, and MCHC levels between 
the bitches with and without mammary tumor were 
in line with the previous reports [12,28,38]. Systemic 
inflammatory response (SIR) affects the survival in 
the several forms of cancer [13]. Also, WBCs have 
a significant role in both SIR and mechanisms in the 
tumor growth and metastasis [24]. Additionally, WBC 
is a potential marker for predicting the progression and 
recurrence of many malignancies [37]. In this study, 
WBC level in grade 3 was significantly higher than 
grade1 (P < 0.05). Whereas levels of WBC in grade 1 
and grade 2 were in referenced laboratory ranges (4.0-
17.6 x 103/μL) [27], it was higher in grade 3. Increased 
level of WBC in grade 3 was supposed to be due to the 
rise in malignancy as previously reported [24,37]. The 
PLT level was detected above the referenced laboratory 
range in 3.3% of the bitches with mammary carcinomas 
[34]. Hemostatic alterations such as PLT, activated 
partial thromboplastin time (aPTT), prothrombin time 
(PT) and fibrinogen were investigated in various type of 
cancer in bitches and it was indicated that 26.6% of the 
bitches with mammary carcinoma had thrombocytosis 
[4]. In this study, while 100% of the bitches in group C 
had PLT levels within the referenced laboratory range 
(110-460 x 103 μL; [27]), 51.16% of group EMT and 
50% of group MMT were within the limits. Throm-
bocytosis was detected in 48.83% and 41.66% of the 
bitches in EMT and MMT groups, respectively. The 
higher percentage of CMTs with thrombocytosis in 
this study may be due to the difference in referenced 
upper limit of PLT in previous studies. Although not 
evaluated in the present and above mentioned studies 
[4,34], the elapsed time between tumor formation and 
clinical presentation may be another influencing factor. 
The PLT count has predictive value in various cancer 
types in humans [17]. The researchers [3] evaluated 
the influence of cancer type on the hemostatic pa-
rameters of the dogs and they reported no significant 
difference between the cancer types for PLT. Although 
there was no significance between PLT levels among 
the study groups, both were significantly higher than 
the group C. Results of this study also showed that the 
predictive role of PLT could also be said for malignant 
CMTs. Increased levels of MPV in humans have been 
a predictive and prognostic factor for invasive breast 
cancer [15]. The mean MPV level in the control group 
was significantly higher than humans with lung cancer 
[26]. In contrast with Gu et al. [15] but in line with 
Oncel et al. [26], in this study the MPV level in group 
C was higher than in group MMT. Under normal cir-
cumstances, there is an inverse relationship between 
the number and volume of PLT. When PLTs decrease 
in number, bone marrow megakaryocytes are stimu-
lated by thrombopoietin, and their nucleus becomes 
hyperlobulated, with much higher DNA content. These 
stimulated megakaryocytes produce larger PLTs [2]. 
The difference obtained between MMT and C group 
in this study might be due to the view that larger PLTs 
are more active and more responsive against endog-
enous and exogenous stimuli compared to smaller 
PLTs and they may cause consumption of these cells 
[16]. The PCT was investigated in various cancer types 
[18,23,26,39]. Although the researchers [26] reported 
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lower PCT levels in lung cancer patients than healthy 
controls, high PCT levels were detected in ovarian, 
endometrial, and colorectal cancers [18,23,39]. In this 
study, while no significance was obtained between 
group C and group MMT in terms of PCT values, 
significance was determined between group C and 
group EMT. It was thought that PCT level may exhibit 
variable behavior in different species, cancer types and 
histological subtypes.
In bitches with mammary carcinomas, the 
PLT levels were not significantly different within the 
histological grades [34]. Levels of MPV [15] and PCT 
[35] were not significantly associated with the grading 
of HBC. Besides, there was no significant difference 
in PDW according to the stage of HBC [25]. In this 
study, PLT and PLT indices were not significantly dif-
ferent in terms of the histological grading similar with 
the previous reports [15,25,34,35]. Thrombocytosis 
was observed in gynaecological cancers (ovarian, 
endometrial, cervical) in humans associated with poor 
outcomes [32]. High PLT count is associated with 
poor survival rate in breast cancer patients [36]. PLTs 
influence the progression of cancer [29] and they are 
involved in key steps of malignancy progression [7]. 
The researchers [6] evaluated the value of preoperative 
PLT count in endometrial carcinoma patients and it 
was reported that PLT levels were significantly higher 
in grade 3 than in both grade 1 and grade 2. Although 
PLT and PCT values were not significant according to 
the histological grading in this study, both parameters 
were found to be higher in grade 3 than the normal 
reference values [20,27]. Further studies conducted 
with higher populations may lead the differences in 
these parameters to significance.
The association between MPV and hematologi-
cal parameters in invasive HBCs was investigated and 
it was reported that MPV was significantly correlated 
with PLT [15]. Also, MPV was reported to be associated 
with PDW in an inflammatory condition such as enteritis 
[19]. In the presented study, MPV was considerably cor-
related with not only PLT but also PDW and PCT. The 
researchers reported that PCT and PDW were prognostic 
factors in HBCs due to their sensitivity and specificity 
[22,35]. Similarly, in this study, PCT and PLT had high 
sensitivity and specificity to distinct EMT and MMT 
from the healthy bitches. 
CONCLUSION
To the best of our knowledge, this is the first 
study to evaluate the PLT indices and CBC parameters 
in CMTs with regard to histological tumor types and 
grading. In conclusion, the present study showed that 
the bitches with mammary tumors have significantly 
increased PLT values and decreased HCT, HGB and 
MCH values versus the healthy ones, regardless of the 
tumor type. However, in comparison with the control 
group, MPV and MCHC values were different only 
in the MMT group, while PCT and MCV values were 
different only in the EMT group. Also, WBC, PLT and 
PCT values were higher than the referenced laboratory 
ranges in grade 3 tumors. With the support of further 
studies, alterations in the above mentioned parameters 
in bitches may contribute in the diagnosis process, 
management of treatment and may constitute an easy 
way to have an idea about the prognosis of mammary 
tumors.
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